Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Circ Cardiovasc Genet. 2017 Dec;10(6):e001804. doi: 10.1161/CIRCGENETICS.117.001804

Table 3.

Characteristics of the Original Aurora AF Warfarin and Aurora Clinical Avatar Populations

Characteristic Aurora AF Warfarin Population (mean±SD) Aurora Clinical Avatar Population (mean±SD)

Age, year, 67.3±14.43 67.2±14.47

Weight, lb, 199.24±54.71 199.24±54.6

Height, in, 66.78±4.31 66.53±4.32

Gender, %
 Female 53.14 53.10
 Male 46.86 46.90

Race, %
 White 95.18 95.22
 African-American 4.25 4.19
 Asian 0.39 0.40
 Am. Indian/Alaskan 0.18 0.18
 Pacific Islander 0.0001 0.0001

Tobacco, %
 No 90.33 90.67
 Yes 9.66 9.33

Amiodarone, %
 No 88.45 88.49
 Yes 11.54 11.51

Fluvastatin, %
 No 99.97 99.98
 Yes 0.03 0.02

CYP2C9, %
 *1/*1 65.77* 67.39
 *1/*2 14.6* 14.86
 *1/*3 9.11* 9.25
 *2/*2 6.41* 6.51
 *2/*3 1.93* 1.97
 *3/*3 0* 0

VKORC1, %
 G/G 38.54* 38.37
 G/A 44.02* 44.18
 A/A 17.33* 17.45
*

Aurora patient population’s genotypic characteristics were derived from published genotype distributions.35